Skip to main content
. Author manuscript; available in PMC: 2015 Sep 28.
Published in final edited form as: J Control Release. 2014 Jun 28;190:485–499. doi: 10.1016/j.jconrel.2014.06.038

Fig. 2.

Fig. 2

(A) Schematic illustration of PSMA targeted BIND-014 docetaxel loaded polymeric nanoparticles. (B) Depiction of achievable nanomedicine attribtutes, red line represents the optimized properties. (C) CT scan evidencing a remarkable regression of lung metastases in 51 year male patient treated with two cycles of BIND-014. Reproduced with permission from [18].